No Evidence for Increased Risk of Cleft Lip or Cleft Palate among Infants Exposed to Antiretroviral Drugs during Pregnancy in the Antiretroviral Pregnancy Registry

Almenoff J. Tonning J. Gould L. Szarfman A. Hauben M. Ouellet-Hellstrom R. Ball R. Hornbuckle K. Walsh L. Yee C. . Perspectives on the use of data mining in pharmacovigilance. Drug Safety. 2005; 28: 981–1007.

Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2011. Wilmington, NC: Registry Coordinating Center; 2011. Available at http://www.apregistry.com. Accessed January 12, 2012.

Cartsos V. Palaska P. Zavras A. Anti-retroviral prophylaxis and the risk of cleft lip and palate: preliminary signal detection in the FDA AERS database. Cleft Palate Craniofac J. 2012; 49: 118–121.

Correa A. Cragan J. Kucik J. Alverson C. Gilboa S. Balakrishnan R. Strickland M. Duke C. O'Leary L. Riehle-Colarusso T. . Metropolitan Atlanta Congenital Defects Program 40th anniversary edition surveillance report: reporting birth defects surveillance data 1968-2003. Birth Defects Res A. 2007; 79: 65–93. [Erratum 2008; 82: 41-62].

Covington D.L. Tilson H. Elder J. Doi P.A. APR Steering Committee. Assessing teratogenicity of antiviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry. Pharmacoepidemiol Drug Saf. 2004; 13: 537–545.

Tilson H. Doi P. Covington D.L. Parker A. Shields K. White A. The Antiretrovirals in Pregnancy Registry: a fifteenth anniversary celebration. Obstet Gynecol Survey. 2007; 62: 137–148.